Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 55154-0289

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 55154-0289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

40mg Bag Label (95533114 68c6 4983 Bc78 5bde70600c95 00)

Pantoprazole Sodium delayed-release tablets, USP 40 mg, unit dose package containing 10 film-coated tablets. Tablets are described as dark yellow, oval, and unscored with imprint "M P9" on one side. Label includes storage instructions, distributor and manufacturer information, and usage warnings. Manufactured for Mylan Pharmaceuticals and distributed by Safecor Health LLC and Cardinal Health.*

FDA Label Image

Pantoprazole Sodium Structural Formula (Image 01)

Chemical structure of pantoprazole sodium, showing its molecular components including sodium ion and hydrate water molecules, consistent with the active ingredient of Pantoprazole Sodium 40 mg delayed release tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.